Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’: [ESMO Open Volume 6, Issue 5, October 2021, 100252]
- Resource Type
- Erratum
- Source
- In
ESMO Open December 2021 6(6) - Subject
- Language
- ISSN
- 2059-7029